207 related articles for article (PubMed ID: 10198778)
1. The mechanism of biliary lipid secretion and its defects.
Elferink RP; Groen AK
Gastroenterol Clin North Am; 1999 Mar; 28(1):59-74, vi. PubMed ID: 10198778
[TBL] [Abstract][Full Text] [Related]
2. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
3. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
4. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
5. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport.
Beukeveld GJ; In 't Veld G; Havinga R; Groen AK; Wolthers BG; Kuipers F
J Hepatol; 1996 Mar; 24(3):343-52. PubMed ID: 8778203
[TBL] [Abstract][Full Text] [Related]
6. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Prescher M; Kroll T; Schmitt L
Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
[TBL] [Abstract][Full Text] [Related]
7. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
Voshol PJ; Koopen NR; de Vree JM; Havinga R; Princen HM; Elferink RP; Groen AK; Kuipers F
J Hepatol; 2001 Feb; 34(2):202-9. PubMed ID: 11281547
[TBL] [Abstract][Full Text] [Related]
8. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
9. Evolving concepts in the pathophysiology of biliary lipid secretion.
Carrella M; Roda E
Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):643-8. PubMed ID: 10604109
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
12. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.
Crawford AR; Smith AJ; Hatch VC; Oude Elferink RP; Borst P; Crawford JM
J Clin Invest; 1997 Nov; 100(10):2562-7. PubMed ID: 9366571
[TBL] [Abstract][Full Text] [Related]
13. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.
Deleuze JF; Jacquemin E; Dubuisson C; Cresteil D; Dumont M; Erlinger S; Bernard O; Hadchouel M
Hepatology; 1996 Apr; 23(4):904-8. PubMed ID: 8666348
[TBL] [Abstract][Full Text] [Related]
14. Progressive Familial Intrahepatic Cholestasis.
Bull LN; Thompson RJ
Clin Liver Dis; 2018 Nov; 22(4):657-669. PubMed ID: 30266155
[TBL] [Abstract][Full Text] [Related]
15. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.
Wang R; Salem M; Yousef IM; Tuchweber B; Lam P; Childs SJ; Helgason CD; Ackerley C; Phillips MJ; Ling V
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2011-6. PubMed ID: 11172067
[TBL] [Abstract][Full Text] [Related]
16. [Childhood cholestasis and bile transporters].
Hierro L; Jara P
Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
[TBL] [Abstract][Full Text] [Related]
17. Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport.
Elferink RP; Tytgat GN; Groen AK
FASEB J; 1997 Jan; 11(1):19-28. PubMed ID: 9034162
[TBL] [Abstract][Full Text] [Related]
18. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile.
Langheim S; Yu L; von Bergmann K; Lütjohann D; Xu F; Hobbs HH; Cohen JC
J Lipid Res; 2005 Aug; 46(8):1732-8. PubMed ID: 15930516
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
20. Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient mice.
Koopen NR; Wolters H; Voshol P; Stieger B; Vonk RJ; Meier PJ; Kuipers F; Hagenbuch B
J Hepatol; 1999 Jan; 30(1):14-21. PubMed ID: 9927146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
